NVDA vs RDWR

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.

RDWR presents a dichotomy between fundamental health and valuation. While the Piotroski F-Score of 4/9 indicates stable but not strong financial health, the company boasts a pristine balance sheet with negligible debt (D/E 0.04) and exceptional gross margins (80.67%). However, the stock trades at a significant premium to its Graham Number ($9.04) and Intrinsic Value ($13.28), with a PEG ratio of 22.79 suggesting extreme overvaluation relative to current growth. The bullish case rests on explosive earnings growth (123% YoY) and a reasonable forward P/E of 19.75, but bearish technicals and weak insider sentiment temper the outlook.